Allergan Unredacted Emails To Refute Ackman Claims – ValueWalk Premium
Allergan GS Email

Allergan Unredacted Emails To Refute Ackman Claims

The voluminous number of emails and official documents showing private conversations between Allergan, Inc. (NYSE:AGN) executives and outside consultants, to be public in court tomorrow, were unredacted by Allergan with the goal to refute claims by Pershing Square’s Bill Ackman, a source with direct involvement in the situation said.


Allergan emails do not put out false information
Allergan, Inc. (NYSE:AGN) made the decision to release the . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0